Nathan P. Tinker, PhD, Executive Director of New York Biotechnology Association (NYBA.ORG), and representatives of Acorda Therapeutics, Inc. (ACOR), Albany Molecular Research, Inc. (AMRI), and OSI Pharmaceuticals, Inc. (OSIP), Rings the NASDAQ Opening Bell
May 19, 2008 - New York Biotechnology Association
About this Marketsite Event:
Nathan P. Tinker, PhD, Executive Director of New York Biotechnology Association (NYBA.ORG), and representatives of Acorda Therapeutics, Inc. (ACOR), Albany Molecular Research, Inc. (AMRI), and OSI Pharmaceuticals, Inc. (OSIP), preside over the opening bell.
NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to policy makers, the media and the communities in which we work.
NYBA's mission is to support the development and growth of New York's biotechnology industry, and to serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action. NYBA's membership comprises bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here(r), our goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry.
Press Inquiries Only:
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at
jolene.libretto@nasdaq.com. Kindly credit © 2008, The Nasdaq Stock Market, Inc. Reprinted with permission.
Other Photography Inquiries:
For all other photography inquiries, please contact NASDAQ’s photographer, Rob Tannenbaum at
rob.tannenbaum@nasdaq.com.
© 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.
